Background
The plague has caused more fear and terror than perhaps any other infectious disease in the history of humankind. It has laid claim to nearly 200 million lives and has brought about monumental changes such as the end of the Dark Ages and the advancement of clinical research in medicine.[1]
Although still debated by historians, the plague has been responsible for at least 3 great pandemics and multiple epidemics in history. The first spread occurred from the Middle East to the Mediterranean basin during the fifth and sixth centuries AD, killing approximately 50% of the population in these areas. The second pandemic afflicted Europe between the 8th and 14th centuries, destroying nearly 40% of the population. The third pandemic started in approximately 1855 in China, and, although it has been mostly controlled, it is still ongoing.
Alexandre Yersin isolated the plague bacillus, developed an antiserum to combat the disease, and postulated its connection with fleas and rats during the epidemic of 1894. The plague bacillus was named Yersinia pestis in his memory.[2]
Pandemics have succeeded in entrenching the plague in every major continent, with the possible exception of Australia. Unlike smallpox, the plague never will be eradicated. It lives in millions of animals and on billions of fleas that reside on them. It is a disease of the desert, the steppes, the mountains, and the forest.[3]
Although, the plague has been considered a disease of the Middle Ages, multiple outbreaks in India and Africa during the last 20 years have stoked fears of another global pandemic.[4, 5, 2] One reason may be the climatic change brought about by global warming. This change is ideal for increasing the prevalence of Ypestis in the host population. A recent study has estimated a more than 50% increase in the plague host prevalence with an increase of 1 degree Centigrade of the temperature in spring.[6] Another reason may be the increasing population explosion worldwide, which is bringing humans into ever-increasing contact with wildlife. Lastly, the dramatic population increase will contribute to conditions of overcrowding and poor sanitation—conditions ripe for plague hosts and vectors to flourish in.
Additionally, there has been significant concern over the return of plague as a potential biological weapon. In 1347, the Tartars catapulted bodies of plague victims over the city walls during the siege of Kaffa, and, in World War II, the Japanese dropped bombs containing fleas inoculated with Yersinia pestis to infect their enemies with the deadly illness. During the Cold War, the Soviets succeeded in aerosolizing the bacteria and in creating strains of multidrug-resistant Yersinia.[7, 8] Aerosolized Y pestis, causing primary pneumonic plague, has been recognized by bioterrorism experts as having one of the highest potentials as a bioterrorism agent due to its extremely high mortality, its high uptake into enzootic and epizootic animals as well as humans, and its ability to be spread over a large area. It has been classified as a Category A select agent by the CDC.[1]
Pathophysiology
The etiologic agent of the plague is Y pestis, a facultative anaerobic, intracellular, gram-negative bacillus. Significant genomic similarity and conservation of DNA sequences suggest Y pestis evolved from the less virulent Yersinia pseudotuberculosis.[9]
The organism can be transmitted from a host to a human via the bite of a vector (usually a flea), via close contact with infected tissue or body fluids, and via direct inhalation of aerosolized bacteria. Currently, the most common form of transmission involves the bite of an infected flea. More than 200 different rodents and species can serve as hosts.
The vector is usually the rat flea, Xenopsylla cheopis. Thirty different flea species have been identified as able to carry the plague bacillus. Other carriers of plague include ticks and human lice. A flea is shown in the image below.
Here a flea is shown with a blocked proventriculus, equivalent to the gastroesophageal region in man. In nature, this flea would develop a ravenous hunger because of its inability to digest the fibrinoid mass of blood and bacteria. Ensuing a biting of the nearest mammal results in clearing of the proventriculus through regurgitation of thousands of bacteria into the bite wound. Courtesy of United States Army Environmental Hygiene Agency. Rodents resistant to the infection, such as wood rats, kangaroo roots, deer mice, grasshopper mice, and voles, form an enzootic stage that ensures the long-term survival of the bacillus. Occasionally, fleas transfer the bacteria to animals that are susceptible to plague such as ground squirrels (an infected squirrel is shown in the image below), prairie dogs, and chipmunks. In the event of large numbers of host animals dying off, hungry fleas search out new food sources. This is known as an epizootic stage and ensures the spread of the organism to new territory. A sylvatic stage occurs when humans are infected from wild animals. Carnivores with the exception of cats and black-footed ferrets have a fairly strong resistance profile, but they can be transfer vectors. Birds and hoofed animals are seldom infected, and reptiles and fish are resistant to plague.[3]
Rock squirrel in extremis coughing of blood-streaked sputum of pneumonic plague. Courtesy of Ken Gage, PhD, CDC, Fort Collins, CO. Virulent plague bacteria can survive dormant in soil, animal carcasses, grains, flea feces, buried bodies, and dried sputum.[10, 3]
Three forms of the plague exist: bubonic plague, pneumonic plague, and septicemic plague. The bubonic form makes up approximately 80-95% of cases worldwide[2] and is caused by deposition of the bacillus in the skin by the bite of an infected vector. If the vector is a flea, bacillus proliferates in the flea's esophagus, preventing food entry into the stomach. To overcome starvation, the flea begins a blood-sucking rampage. Between its attempts to swallow, the distended bacillus-packed esophagus recoils, depositing the bacillus into the victim's skin.
The bacillus invades nearby lymphoid tissue, producing the famous bubo, an inflamed, necrotic, and hemorrhagic lymph node. Spread occurs along the lymphatic channels toward the thoracic duct, with eventual seeding of the vasculature. Bacteremia and septicemia ensue. The bacillus potentially seeds every organ, including the lungs, liver, spleen, kidneys, and rarely even the meninges.
The most virulent form, pneumonic plague, results from direct inhalation of the bacillus, which occurs from close contact of infected hosts or from aerosolized bacteria such as may occur if used as a biological weapon. A severe and rapidly progressive multilobar bronchopneumonia ensues with subsequent bacteremia and septicemia. Secondary pneumonic plague is caused when an infected patient seeds his or her lungs and airways.
The third type of plague is a primary septicemic plague. This is hypothesized to occur when the bacillus is deposited in the vasculature, bypassing the lymphatics. Early dissemination with sepsis occurs but without the formation of a bubo. This usually is observed in bites to the oral, tonsillar, and pharyngeal area and is believed to occur because of the vascularity of the tissue and short lymphatic distance to the thoracic duct.
Epidemiology
Frequency
United States
An average of 10-15 cases per year have been reported during the last few decades. One of the largest animal foci of the plague worldwide is found west of the 100th parallel, in states such as New Mexico, Arizona, Colorado, Utah, and California. Only one case of imported plague has been reported since 1926. Most cases occur during the wet, warmer months of the year.[11] In 2006, 13 human plague cases were reported in the United States, the most since 1994.
International
From 1987-2001, the World Health Organization has reported an annual average of 38,876 cases of the plague with 2847 deaths worldwide. The number of actual cases is probably much higher, given the failure of many countries to diagnose and report the plague. Most cases occur in the developing countries of Africa and Asia. Recent outbreaks of the plague have occurred in Vietnam, India, Algeria, Madagascar, and the northeastern part of the Democratic Republic of the Congo.[12] During 2000-2001, 95% of the world's cases occurred in Africa.[2]
The illustration below shows the distribution of the plague in 1998.
World distribution of plague, 1998. From the Centers for Disease Control and Prevention (CDC), Atlanta, Ga. Mortality/Morbidity
- Bubonic plague has a 1-15% mortality rate in treated cases and a 40-60% mortality rate in untreated cases.
- Septicemic plague (primary or secondary) has a 40% mortality rate in treated cases and 100% mortality rate in untreated cases.
- Pneumonic plague (primary or secondary) has 100% mortality rate if not treated within the first 24 hours of infection.
Sex
More than 50% of cases of plague occur in males.
Age
Approximately 50% of cases occur in persons younger than 20 years.
Kman NE, Nelson RN. Infectious agents of bioterrorism: a review for emergency physicians. Emerg Med Clin North Am. May 2008;26(2):517-47, x-xi. [Medline].
Prentice MB, Rahalison L. Plague. Lancet. Apr 7 2007;369(9568):1196-207. [Medline].
Casman EA, Fischhoff B. Risk communication planning for the aftermath of a plague bioattack. Risk Anal. Oct 2008;28(5):1327-42. [Medline].
Joshi K, Thakur JS, Kumar R, Singh AJ, Ray P, Jain S, et al. Epidemiological features of pneumonic plague outbreak in Himachal Pradesh, India. Trans R Soc Trop Med Hyg. May 2009;103(5):455-60. [Medline].
Bertherat E, Bekhoucha S, Chougrani S, Razik F, Duchemin JB, Houti L, et al. Plague reappearance in Algeria after 50 years, 2003. Emerg Infect Dis. Oct 2007;13(10):1459-62. [Medline].
Stenseth NC, Samia NI, Viljugrein H, Kausrud KL, Begon M, Davis S, et al. Plague dynamics are driven by climate variation. Proc Natl Acad Sci U S A. Aug 29 2006;103(35):13110-5. [Medline].
Smiley ST. Immune defense against pneumonic plague. Immunol Rev. Oct 2008;225:256-71. [Medline].
Kummer LW, Szaba FM, Parent MA, Adamovicz JJ, Hill J, Johnson LL. Antibodies and cytokines independently protect against pneumonic plague. Vaccine. Dec 9 2008;26(52):6901-7. [Medline].
Blisnick T, Ave P, Huerre M, Carniel E, Demeure CE. Oral vaccination against bubonic plague using a live avirulent Yersinia pseudotuberculosis strain. Infect Immun. Aug 2008;76(8):3808-16. [Medline].
Ayyadurai S, Houhamdi L, Lepidi H, Nappez C, Raoult D, Drancourt M. Long-term persistence of virulent Yersinia pestis in soil. Microbiology. Sep 2008;154:2865-71. [Medline].
Ben Ari T, Gershunov A, Gage KL, Snall T, Ettestad P, Kausrud KL, et al. Human plague in the USA: the importance of regional and local climate. Biol Lett. Dec 23 2008;4(6):737-40. [Medline].
Bertherat E, Bekhoucha S, Chougrani S, Razik F, Duchemin JB, Houti L. Plague reappearance in Algeria after 50 years, 2003. Emerg Infect Dis. Oct 2007;13(10):1459-62. [Medline].
Margolis DA, Burns J, Reed SL, Ginsberg MM, O'Grady TC, Vinetz JM. Septicemic plague in a community hospital in California. Am J Trop Med Hyg. Jun 2008;78(6):868-71. [Medline].
Waterer GW, Robertson H. Bioterrorism for the respiratory physician. Respirology. Jan 2009;14(1):5-11. [Medline].
Barnes AM, Quam TJ. Plague. In: Gorbach SL, Bartlett JG, Balacklow NR, eds. Infectious Diseases. 1992:1285-91.
Branda JA, Ruoff K. Bioterrorism. Clinical recognition and primary management. Am J Clin Pathol. Jun 2002;117 Suppl:S116-23. [Medline].
Burmeister RW, Tigertt WD, Overholt EL. Laboratory-acquired pneumonic plague. Report of a case and review of previous cases. Ann Intern Med. May 1962;56:789-800. [Medline].
Butler T. Yersinia species (including plagues). In: Mandell GL, Douglas RG Jr, Bennett JE, eds. Principles and Practice of Infectious Diseases. 3rd ed. 1990.
Butler T, Bell WR, Nguyen-Ngoc-Linh, Nguyen-Dinh-Tiep, Arnold K. Yersinia pestis infection in Vietnam. I. Clinical and hematologic aspects. J Infect Dis. May 1974;129:Suppl:S78-84. [Medline].
CDC. Human plague--United States, 1993-1994. MMWR Morb Mortal Wkly Rep. Apr 8 1994;43(13):242-6. [Medline].
Chanteau S, Rahalison L, Ralafiarisoa L, Foulon J, Ratsitorahina M, Ratsifasoamanana L. Development and testing of a rapid diagnostic test for bubonic and pneumonic plague. Lancet. Jan 18 2003;361(9353):211-6. [Medline].
Christie AB, Corbel MS. Topley and Wilson, eds. Principles of Bacteriology, Virology and Immunity. 3rd-8th ed. 1990:400-9.
Conner C. Plague. In: Pathology of Infectious Diseases. 1997:729-38.
Connor JD, Williams RA, Thompson MA, et al. Plague in San Diego [clinical conference]. West J Med. Nov 1978;129(5):394-406. [Medline].
Craven RB, Maupin GO, Beard ML, et al. Reported cases of human plague infections in the United States, 1970- 1991. J Med Entomol. Jul 1993;30(4):758-61. [Medline].
Crook LD, Tempest B. Plague. A clinical review of 27 cases. Arch Intern Med. Jun 1992;152(6):1253-6. [Medline].
Hoffman SL. Plague in the United States: the "black death" is still alive. Ann Emerg Med. Jun 1980;9(6):319-22. [Medline].
Hull HF, Montes JM, Mann JM. Septicemic plague in New Mexico. J Infect Dis. Jan 1987;155(1):113-8. [Medline].
Human plague--four states, 2006. MMWR Morb Mortal Wkly Rep. Sep 1 2006;55(34):940-3. [Medline].
Humphrey M, McGivney R, Perkins C, Harris R, Rowe J. Yersinia pestis: a case of mistaken identity. Pediatr Infect Dis J. May 1988;7(5):365-6. [Medline].
Koirala J. Plague: disease, management, and recognition of act of terrorism. Infect Dis Clin North Am. Jun 2006;20(2):273-87, viii. [Medline].
Kool JL. Risk of person-to-person transmission of pneumonic plague. Clin Infect Dis. Apr 15 2005;40(8):1166-72. [Medline].
Lazarus AA, Decker CF. Plague. Respir Care Clin N Am. Mar 2004;10(1):83-98. [Medline].
Leopold JC. Septicemic plague in a 14-month-old child. Pediatr Infect Dis. Jan-Feb 1986;5(1):108-10. [Medline].
Mann JM, Hull HF, Schmid GP, Droke WE. Plague and the peripheral smear. JAMA. Feb 17 1984;251(7):953. [Medline].
Marcus LC. Wilderness acquired zoonoses. In: Auerbach PS, Geehr EC, eds. Management of Wilderness and Environmental Emergencies. 1989.
McGovern TW, Christopher GW, Eitzen EM. Cutaneous manifestations of biological warfare and related threat agents. Arch Dermatol. Mar 1999;135(3):311-22. [Medline].
McGovern TW, Friedlander AM. Plague. Textbook of Military Medicine: Medical Aspects of Chemical and Biological Warfare. In: Sidell FR, Takafuji ET, Franz DR, Zajtchuk R, Bellamy RF, eds. eds. Textbook of Military Medicine: Medical Aspects of Chemical and Biological Warfare. Textbook of Military Medicine. Office of the Surgeon General of the Army; 1997:479-502.
Mwengee W, Butler T, Mgema S, Mhina G, Almasi Y, Bradley C. Treatment of plague with gentamicin or doxycycline in a randomized clinical trial in Tanzania. Clin Infect Dis. Mar 1 2006;42(5):614-21. [Medline].
Navas E. Problems associated with potential massive use of antimicrobial agents as prophylaxis or therapy of a bioterrorist attack. Clin Microbiol Infect. Aug 2002;8(8):534-9. [Medline].
Outbreak news. Plague, Democratic Republic of the Congo. Wkly Epidemiol Rec. Oct 20 2006;81(42):397-8. [Medline].
Perry RD, Fetherston JD. Yersinia pestis--etiologic agent of plague. Clin Microbiol Rev. Jan 1997;10(1):35-66. [Medline].
Rollins SE, Rollins SM, Ryan ET. Yersinia pestis and the plague. Am J Clin Pathol. Jun 2003;119 Suppl:S78-85. [Medline].
Rotz LD, Khan AS, Lillibridge SR, Ostroff SM, Hughes JM. Public health assessment of potential biological terrorism agents. Emerg Infect Dis. Feb 2002;8(2):225-30. [Medline].
Stenseth NC, Samia NI, Viljugrein H, Kausrud KL, Begon M, Davis S. Plague dynamics are driven by climate variation. Proc Natl Acad Sci U S A. Aug 29 2006;103(35):13110-5. [Medline].
Weir E. Plague: a continuing threat. CMAJ. Jun 7 2005;172(12):1555. [Medline].
Welty TK, Grabman J, Kompare E, et al. Nineteen cases of plague in Arizona. A spectrum including ecthyma gangrenosum due to plague and plague in pregnancy. West J Med. May 1985;142(5):641-6. [Medline].
Werner SB, Weidmer CE, Nelson BC, Nygaard GS, Goethals RM, Poland JD. Primary plague pneumonia contracted from a domestic cat at South Lake Tahoe, Calif. JAMA. Feb 17 1984;251(7):929-31. [Medline].

